Department of Radiology, Center for Nonlinear and Complex Systems, Duke University Medical Center, Box 3808, Erwin St, Durham, NC 27710, USA.
Radiology. 2009 Dec;253(3):870-8. doi: 10.1148/radiol.2533081086. Epub 2009 Sep 29.
To evaluate a widely used nontunneled triple-lumen central venous catheter in order to determine whether the largest of the three lumina (16 gauge) can tolerate high flow rates, such as those required for computed tomographic angiography.
Forty-two catheters were tested in vitro, including 10 new and 32 used catheters (median indwelling time, 5 days). Injection pressures were continuously monitored at the site of the 16-gauge central venous catheter hub. Catheters were injected with 300 and 370 mg of iodine per milliliter of iopamidol by using a mechanical injector at increasing flow rates until the catheter failed. The infusion rate, hub pressure, and location were documented for each failure event. The catheter pressures generated during hand injection by five operators were also analyzed. Mean flow rates and pressures at failure were compared by means of two-tailed Student t test, with differences considered significant at P < .05.
Injections of iopamidol with 370 mg of iodine per milliliter generate more pressure than injections of iopamidol with 300 mg of iodine per milliliter at the same injection rate. All catheters failed in the tubing external to the patient. The lowest flow rate at which catheter failure occurred was 9 mL/sec. The lowest hub pressure at failure was 262 pounds per square inch gauge (psig) for new and 213 psig for used catheters. Hand injection of iopamidol with 300 mg of iodine per milliliter generated peak hub pressures ranging from 35 to 72 psig, corresponding to flow rates ranging from 2.5 to 5.0 mL/sec.
Indwelling use has an effect on catheter material property, but even for used catheters there is a substantial safety margin for power injection with the particular triple-lumen central venous catheter tested in this study, as the manufacturer's recommendation for maximum pressure is 15 psig.
评估一种广泛使用的非隧道式三腔中央静脉导管,以确定三个腔中最大的腔(16 号)是否能承受高流速,如计算机断层血管造影所需的流速。
在体外测试了 42 根导管,包括 10 根新导管和 32 根使用过的导管(中位留置时间为 5 天)。在 16 号中央静脉导管接头处连续监测注射压力。使用机械注射器以递增的流速向导管内注射每毫升含 300 毫克和 370 毫克碘的碘帕醇,直至导管失效。记录每次失效事件的输注率、接头压力和位置。还分析了 5 名操作人员手动注射时产生的导管压力。使用双尾学生 t 检验比较平均流速和失效压力,差异 P <.05 时认为有统计学意义。
以相同的注射速率注射含 370 毫克碘/毫升的碘帕醇比注射含 300 毫克碘/毫升的碘帕醇产生的压力更大。所有导管均在患者体外的导管处失效。导管失效时的最低流速为 9 毫升/秒。新导管失效时的最低接头压力为 262 磅/平方英寸表压(psig),使用过的导管为 213 psig。手动注射含 300 毫克碘/毫升的碘帕醇时,接头处的峰值压力范围为 35 至 72 psig,相应的流速范围为 2.5 至 5.0 毫升/秒。
留置使用对导管材料性能有影响,但即使对于使用过的导管,在本研究中测试的特定三腔中央静脉导管中,动力注射仍有很大的安全裕度,因为制造商建议的最大压力为 15 psig。